Gentile Kimberly's Insider Trades & SAST Disclosures
Gentile Kimberly's most recent trade in Biohaven Ltd was a trade of 91,000 Stock Options (Right to buy) done . Disclosure was reported to the exchange on Jan. 5, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Gentile Kimberly.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Biohaven Ltd | Kimberly Gentile | SVP, Clinical Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2025 | 91,000 | 91,000 | - | - | Stock Options (Right to buy) | |
| Biohaven Ltd | Kimberly Gentile | SVP, Clinical Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2025 | 15,000 | 15,000 | - | - | Restricted Share Unit Award | |
| Biohaven Ltd | Kimberly Gentile | SVP, Clinical Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2025 | 3,750 | 99,719 | - | 0 | Common Shares | |
| Biohaven Ltd | Kimberly Gentile | SVP, Clinical Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2025 | 3,750 | 11,250 | - | - | Restricted Share Unit Award | |
| Biohaven Ltd | Kimberly Gentile | SVP, Clinical Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.64 per share. | 05 Jan 2025 | 1,956 | 97,763 | - | 38.6 | 75,580 | Common Shares |
| Biohaven Ltd | Gentile Kimberly | SVP, Clinical Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 96,250 | 96,250 | - | - | Stock Options (Right to buy) | |
| Biohaven Ltd | Kimberly Gentile | SVP, Clinical Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Nov 2023 | 78,750 | 78,750 | - | - | Stock Options (Right to buy) | |
| Biohaven Ltd | Kimberly Gentile | SVP, Clinical Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 300,000 | 300,000 | - | - | Stock Options (Right to buy) | |
| Biohaven Ltd | Kimberly Gentile | SVP, Clinical Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.00 per share. | 03 Oct 2022 | 37,492 | 95,969 | - | 7 | 262,444 | Common Shares |
| Biohaven Ltd | Kimberly Gentile | SVP, Clinical Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.61 per share. | 03 Oct 2022 | 30,958 | 93,908 | - | 1.6 | 49,842 | Common Shares |
| Biohaven Ltd | Kimberly Gentile | SVP, Clinical Operations | Other type of transaction at price $ 0.00 per share. | 03 Oct 2022 | 30,958 | 30,958 | - | - | Stock Options (Right to Buy) | |
| Biohaven Ltd | Kimberly Gentile | SVP, Clinical Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 30,958 | 0 | - | - | Stock Options (Right to Buy) | |
| Biohaven Ltd | Kimberly Gentile | SVP, Clinical Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.03 per share. | 03 Oct 2022 | 20,716 | 116,461 | - | 1.0 | 21,337 | Common Shares |
| Biohaven Ltd | Kimberly Gentile | SVP, Clinical Operations | Other type of transaction at price $ 0.00 per share. | 03 Oct 2022 | 20,716 | 20,716 | - | - | Stock Options (Right to Buy) | |
| Biohaven Ltd | Kimberly Gentile | SVP, Clinical Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 20,716 | 0 | - | - | Stock Options (Right to Buy) | |
| Biohaven Ltd | Kimberly Gentile | SVP, Clinical Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.84 per share. | 03 Oct 2022 | 14,000 | 59,950 | - | 2.8 | 39,760 | Common Shares |
| Biohaven Ltd | Kimberly Gentile | SVP, Clinical Operations | Other type of transaction at price $ 0.00 per share. | 03 Oct 2022 | 14,000 | 14,000 | - | - | Stock Options (Right to Buy) | |
| Biohaven Ltd | Kimberly Gentile | SVP, Clinical Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 14,000 | 0 | - | - | Stock Options (Right to Buy) | |
| Biohaven Ltd | Kimberly Gentile | SVP, Clinical Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.13 per share. | 03 Oct 2022 | 13,801 | 45,950 | - | 4.1 | 56,998 | Common Shares |
| Biohaven Ltd | Kimberly Gentile | SVP, Clinical Operations | Other type of transaction at price $ 0.00 per share. | 03 Oct 2022 | 13,801 | 13,801 | - | - | Stock Options (Right to Buy) | |
| Biohaven Ltd | Kimberly Gentile | SVP, Clinical Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 13,801 | 0 | - | - | Stock Options (Right to Buy) | |
| Biohaven Ltd | Kimberly Gentile | SVP, Clinical Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.37 per share. | 03 Oct 2022 | 12,612 | 30,950 | - | 6.4 | 80,338 | Common Shares |
| Biohaven Ltd | Kimberly Gentile | SVP, Clinical Operations | Other type of transaction at price $ 0.00 per share. | 03 Oct 2022 | 12,612 | 12,612 | - | - | Stock Options (Right to Buy) | |
| Biohaven Ltd | Kimberly Gentile | SVP, Clinical Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 12,612 | 0 | - | - | Stock Options (Right to Buy) | |
| Biohaven Ltd | Kimberly Gentile | SVP, Clinical Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 12,500 | 0 | - | - | Stock Option (Right to Buy) | |
| Biohaven Ltd | Kimberly Gentile | SVP, Clinical Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.54 per share. | 03 Oct 2022 | 12,500 | 133,461 | - | 0.5 | 6,750 | Common Shares |
| Biohaven Ltd | Kimberly Gentile | SVP, Clinical Operations | Other type of transaction at price $ 0.00 per share. | 03 Oct 2022 | 12,500 | 12,500 | - | - | Stock Options (Right to Buy) | |
| Biohaven Ltd | Kimberly Gentile | SVP, Clinical Operations | Other type of transaction at price $ 0.00 per share. | 03 Oct 2022 | 6,500 | 12,326 | - | 0 | Common Shares | |
| Biohaven Ltd | Kimberly Gentile | SVP, Clinical Operations | Other type of transaction at price $ 0.00 per share. | 03 Oct 2022 | 5,826 | 5,826 | - | 0 | Common Shares | |
| Biohaven Ltd | Kimberly Gentile | SVP, Clinical Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.86 per share. | 03 Oct 2022 | 4,500 | 120,961 | - | 1.9 | 8,370 | Common Shares |
| Biohaven Ltd | Kimberly Gentile | SVP, Clinical Operations | Other type of transaction at price $ 0.00 per share. | 03 Oct 2022 | 4,500 | 4,500 | - | - | Stock Options (Right to Buy) | |
| Biohaven Ltd | Kimberly Gentile | SVP, Clinical Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 4,500 | 0 | - | - | Stock Options (Right to buy) | |
| Biohaven Ltd | Kimberly Gentile | SVP, Clinical Operations | Other type of transaction at price $ 0.00 per share. | 03 Oct 2022 | 3,750 | 16,076 | - | 0 | Common Shares | |
| Biohaven Ltd | Kimberly Gentile | SVP, Clinical Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.52 per share. | 03 Oct 2022 | 3,000 | 62,950 | - | 2.5 | 7,560 | Common Shares |
| Biohaven Ltd | Kimberly Gentile | SVP, Clinical Operations | Other type of transaction at price $ 0.00 per share. | 03 Oct 2022 | 3,000 | 3,000 | - | - | Stock Options (Right to Buy) | |
| Biohaven Ltd | Kimberly Gentile | SVP, Clinical Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 3,000 | 0 | - | - | Stock Options (Right to Buy) | |
| Biohaven Ltd | Kimberly Gentile | SVP, Clinical Operations | Other type of transaction at price $ 0.00 per share. | 03 Oct 2022 | 1,875 | 17,951 | - | 0 | Common Shares | |
| Biohaven Ltd | Kimberly Gentile | SVP, Clinical Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.61 per share. | 03 Oct 2022 | 1,542 | 95,450 | - | 1.6 | 2,483 | Common Shares |
| Biohaven Ltd | Kimberly Gentile | SVP, Clinical Operations | Other type of transaction at price $ 0.00 per share. | 03 Oct 2022 | 1,542 | 1,542 | - | - | Stock Options (Right to Buy) | |
| Biohaven Ltd | Kimberly Gentile | SVP, Clinical Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 1,542 | 0 | - | - | Stock Options (Right to Buy) | |
| Biohaven Ltd | Kimberly Gentile | SVP, Clinical Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.13 per share. | 03 Oct 2022 | 1,199 | 32,149 | - | 4.1 | 4,952 | Common Shares |
| Biohaven Ltd | Kimberly Gentile | SVP, Clinical Operations | Other type of transaction at price $ 0.00 per share. | 03 Oct 2022 | 1,199 | 1,199 | - | - | Stock Options (Right to Buy) | |
| Biohaven Ltd | Kimberly Gentile | SVP, Clinical Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 1,199 | 0 | - | - | Stock Options (Right to Buy) | |
| Biohaven Ltd | Kimberly Gentile | SVP, Clinical Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.37 per share. | 03 Oct 2022 | 387 | 18,338 | - | 6.4 | 2,465 | Common Shares |
| Biohaven Ltd | Kimberly Gentile | SVP, Clinical Operations | Other type of transaction at price $ 0.00 per share. | 03 Oct 2022 | 387 | 387 | - | - | Stock Options (Right to Buy) | |
| Biohaven Ltd | Kimberly Gentile | SVP, Clinical Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 387 | 0 | - | - | Stock Options (Right to Buy) | |
| Biohaven Ltd | Kimberly Gentile | SVP, Clinical Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.03 per share. | 03 Oct 2022 | 295 | 95,745 | - | 1.0 | 304 | Common Shares |
| Biohaven Ltd | Kimberly Gentile | SVP, Clinical Operations | Other type of transaction at price $ 0.00 per share. | 03 Oct 2022 | 295 | 295 | - | - | Stock Options (Right to Buy) | |
| Biohaven Ltd | Kimberly Gentile | SVP, Clinical Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 295 | 0 | - | - | Stock Options (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges